Prot #R5668-ONC-1938: Phase 1/2 Study of REGN5668 (MUC16 X CD28, a Costimulatory Bispecfic) Administered in Combination with Cemiplimab OR REGN4018 (MUC16 X CD3)

Project: Research project

Project Details

StatusActive
Effective start/end date1/7/22 → 1/7/28

Funding

  • PPD Investigator Services, LLC ((OE) Prot #R5668-ONC-1938 Amd 1 // (OE) Prot #R5668-ONC-1938 ...)
  • Regeneron Pharmaceuticals, Inc. ((OE) Prot #R5668-ONC-1938 Amd 1 // (OE) Prot #R5668-ONC-1938 ...)